百时美施贵宝投资Janux的“掩蔽”T细胞接合剂技术。
Bristol Myers buys into Janux’s ‘masked’ T cell engagers
生物技术与制药领域的最新动态
Bristol Myers buys into Janux’s ‘masked’ T cell engagers
Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2
Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target
Mechanistic insights into fatty acid odor detection mediated by class II olfactory receptors
BMS pens $850M solid tumor pact with T-cell engager biotech Janux
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance New Zealand
The cellular logic of limb regeneration
Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat
Novacell Technology reports new FPR2 agonists
Anti-resonance in developmental signaling regulates cell fate decisions
cxcl18b-defined transitional state-specific nitric oxide drives injury-induced Müller glia cell-cycle re-entry in the zebrafish retina
The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance
The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance Singapore
Identification of a sub-population of synovial mesenchymal stem cells with enhanced treatment efficacy in a rat model of osteoarthritis
Single-cell profiling of trabecular meshwork identifies mitochondrial dysfunction in a glaucoma model that is protected by vitamin B3 treatment
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity
Nanoparticles hijack calvarial immune cells for CNS drug delivery and stroke therapy
Continuum architecture dynamics of vesicle tethering in exocytosis